GlaxoSmithKline's ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool
GlaxoSmithKline's AIDS drugs business is to add one of its latest HIV medicines to a patent pool - cutting its future price for developing countries and pooling intellectual property rights.
No comments:
Post a Comment